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Inhibitor-resistant TEM (IRT) ␤-lactamases derive from TEM-1 or TEM-2 enzymes by point mutations in the corresponding coding gene (http://www.lahey.org/studies). Inhibitor-resistant SHV (IRS) ␤-lactamases are less commonly identified than IRT enzymes, and mainly in Klebsiella pneumoniae strains (3, 4, 5, 8, 9) . In this study, we performed a phenotypic, molecular, and biochemical characterization of a new IRS enzyme, SHV-84, produced by a clinical Escherichia coli strain.
E. coli INSRA4590 was isolated from a patient admitted in 1999 to Centro Hospitalar de Coimbra, Portugal. Antimicrobial susceptibility, isoelectric focusing for isoelectric point determination, identification of ␤-lactamase-encoding genes, and extraction and purification of a new ␤-lactamase were performed as previously described (1, 7) . Antimicrobial susceptibility results were interpreted by using French Society of Microbiology criteria (2) . E. coli INSRA4590 exhibited high-level resistance to the penicillins tested (except piperacillin) and to the combination of amoxicillin and clavulanic acid but was susceptible to the combination of piperacillin and tazobactam (Table 1) ; it was susceptible to all cephalosporins tested and to aztreonam.
The clinical strain expressed SHV-1 with a pI of 7.6 and the new SHV-84 ␤-lactamase with a pI of 7.4, which differed from SHV-1 by the amino acid substitution Lys234Arg. This mutation has been described in other IRS enzymes, such as SHV-56 (5) and SHV-72 (also encountered in Portugal) (8) , in which it was associated with the substitution Leu35Gln and the substitutions Ile8Phe and Ala146Val, respectively. The recombinant SHV-encoding plasmid (pBK-SHV-84) and the corresponding transformant E. coli DH5␣ were obtained as previously described (8) . The SHV-84-producing transformant DH5␣-SHV-84 exhibited a ␤-lactam resistance phenotype similar to that of the clinical strain (Table 1) , and the corresponding ␤-lactamase had a pI of 7.4.
The kinetic constants of the purified enzyme (Ն99% pure; data not shown) and the concentrations of inhibitors required to inhibit enzyme activity by 50% (IC 50 s) were determined as previously reported (6, 8) In conclusion, this study underlines the importance of the Lys234Arg substitution in resistance to clavulanic acid in nature, since we demonstrate that this mutation alone is responsible for decreased susceptibility to ␤-lactamase inhibitors. These results corroborate those previously obtained by molecular dynamic simulation in a study using the model of the mutant SHV-72 enzyme, in which the authors suggested a change in the positioning of the Ser130 side chain induced by Arg234 (8) .
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